The Impact of Acellular Dermal Matrix on Tissue Expander/Implant Loss in Breast Reconstruction
Authors:
- Christopher J. PannucciCPChristopher J. Pannucci
- Anuja K. AntonyAAAnuja K. Antony
- Edwin G. WilkinsEWEdwin G. Wilkins
- 1 July 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 132 (1) , 1-10
Abstract
Use of acellular dermal matrix in breast reconstruction has been associated with increased complications. However, existing studies are generally small, from single centers, and underpowered to control for confounding using regression techniques. Here, the Tracking Outcomes and Operations in Plastic Surgery database was used to examine the effect of acellular dermal matrix on expander/implant loss when controlling for other confounders. Analysis was limited to patients having tissue expander or implant-based breast reconstruction. Surgeon-reported data, International Classification of Diseases, Ninth Edition codes, and Current Procedural Terminology codes were used to identify independent variables. The dependent variable of interest was 30-day rates of tissue expander or implant loss. Bivariate statistics were performed. Multivariable logistic regression identified independent predictors of expander/implant loss when controlling for other confounders. Data were available for 14,249 patients. The overall rate of expander/implant loss was 2.05 percent. Bivariate analysis demonstrated acellular dermal matrix was associated with an absolute increase in expander/implant loss of 0.7 percent (1.88 percent versus 2.58 percent, p = 0.012). The regression model demonstrated that rising body mass index, current smoking, and presence of diabetes were each independent predictors of expander/implant loss. When controlling for all other identified confounders, use of acellular dermal matrix was associated with a significant increase in expander/implant loss (odds ratio, 1.42; 95 percent confidence interval, 1.04 to 1.94; p = 0.026). Thirty-day risk for expander/implant loss after tissue expander or implant-based breast reconstruction was 2.05 percent. Use of acellular dermal matrix was associated with a 0.7 percent absolute risk increase for expander/implant loss. Risk, III.Keywords
This publication has 16 references indexed in Scilit:
- A Systematic Review and Meta-Analysis of Complications Associated With Acellular Dermal Matrix-Assisted Breast ReconstructionAnnals of Plastic Surgery, 2012
- Extended Trimethoprim/Sulfamethoxazole Prophylaxis for Implant Reconstruction in the Previously Irradiated Chest WallPlastic and Reconstructive Surgery, 2012
- Use of human acellular dermal matrix in implant- based breast reconstruction: Evaluating the evidenceJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Acellular Dermis–Assisted Prosthetic Breast ReconstructionPlastic and Reconstructive Surgery, 2011
- Comparison of Implant-Based Immediate Breast Reconstruction with and without Acellular Dermal MatrixPlastic and Reconstructive Surgery, 2011
- Statistics in MedicinePlastic and Reconstructive Surgery, 2011
- Acellular Human Dermis Implantation in 153 Immediate Two-Stage Tissue Expander Breast Reconstructions: Determining the Incidence and Significant Predictors of ComplicationsPlastic and Reconstructive Surgery, 2010
- The Effect of Acellular Dermal Matrix Use on Complication Rates in Tissue Expander/Implant Breast ReconstructionAnnals of Plastic Surgery, 2010
- Implant-Based Breast Reconstruction Using Acellular Dermal Matrix and the Risk of Postoperative ComplicationsPlastic and Reconstructive Surgery, 2010
- Acellular Dermis–Assisted Prosthetic Breast Reconstruction versus Complete Submuscular Coverage: A Head-to-Head Comparison of OutcomesPlastic and Reconstructive Surgery, 2009